Could PD-L1 Prove to be an Effective Therapeutic Target for Bladder Cancer?
Year: 2015
Type: article
Source: Immunotherapy
DOI: 10.2217/imt.14.110
Authors: Navid Hafez, Daniel P Petrylak
Institutions: Yale Cancer Center, Yale University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2049030378
